glp-1 agonists for diabetes GLP1 Receptor Agonists vs SGLT2-I

Sima E, Webb DL, Hellstrm PM, Sundbom M

American Society of Anesthesiologists consensus-based guidance on preoperative management of patients (adults and children) on GLP-1 receptor agonists

Imeryz N, Yeen BC, Bozkurt A, Cokun T, Villanueva-Peacarrillo ML, Ulusoy NB

Brain site-specific inhibitory effects of the GLP-1 analogue exendin-4 on alcohol intake and operant responding for palatable food

Outcomes In the overall analysis, the risk of MACE was reduced by 14% (HR = 0.86, 95% CI, 0.790.94, P = 0.006) compared with placebo with no significant heterogeneity between trials (I 2 = 50.0%, P = 0.08) (Fig

List of adverse reactions of SSIBs included in this study